Europlasma SA Total Liabilities
Europlasma SA total liabilities. Based on the latest financial reports, Europlasma SA (ALEUP) has total liabilities worth €106.17 Million EUR (≈ $124.13 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Europlasma SA to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Europlasma SA (2000–2024)
Total liabilities of Europlasma SA from 2000 to 2024. This chart illustrates how Europlasma SA's total liabilities have evolved over time, based on quarterly financial data. Check Europlasma SA (ALEUP) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Europlasma SA Competitors by Total Liabilities
The table below lists competitors of Europlasma SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Union Jack Oil plc
LSE:UJO
|
UK | GBX3.07 Million |
|
XLMedia PLC
LSE:XLM
|
UK | GBX24.32 Million |
|
Malvern International
LSE:MLVN
|
UK | GBX13.30 Million |
|
STRATA Skin Sciences Inc
NASDAQ:SSKN
|
USA | $27.61 Million |
|
Mobile Max-M
TA:MBMX
|
Israel | ILA2.40 Million |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
USA | $7.42 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Europlasma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Europlasma SA asset portfolio.
Liquidity & Leverage Metrics
Europlasma SA Total Liabilities Ratios Explained
Europlasma SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Europlasma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Europlasma SA (2000–2024)
The table below shows the annual total liabilities of Europlasma SA from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €74.05 Million ≈ $86.57 Million |
+48.05% |
| 2023-12-31 | €50.02 Million ≈ $58.47 Million |
+2.37% |
| 2022-12-31 | €48.86 Million ≈ $57.12 Million |
+35.84% |
| 2021-12-31 | €35.97 Million ≈ $42.05 Million |
-15.86% |
| 2020-12-31 | €42.75 Million ≈ $49.97 Million |
-26.32% |
| 2019-12-31 | €58.01 Million ≈ $67.82 Million |
-12.18% |
| 2018-12-31 | €66.06 Million ≈ $77.23 Million |
+7.53% |
| 2017-12-31 | €61.43 Million ≈ $71.82 Million |
+32.78% |
| 2016-12-31 | €46.26 Million ≈ $54.09 Million |
+12.16% |
| 2015-12-31 | €41.25 Million ≈ $48.22 Million |
-4.92% |
| 2014-12-31 | €43.38 Million ≈ $50.72 Million |
-3.96% |
| 2013-12-31 | €45.17 Million ≈ $52.81 Million |
-20.84% |
| 2012-12-31 | €57.06 Million ≈ $66.70 Million |
+10.80% |
| 2011-12-31 | €51.49 Million ≈ $60.20 Million |
+64.34% |
| 2010-12-31 | €31.33 Million ≈ $36.63 Million |
+6.20% |
| 2009-12-31 | €29.50 Million ≈ $34.49 Million |
+38.22% |
| 2008-12-31 | €21.35 Million ≈ $24.96 Million |
+27.53% |
| 2007-12-31 | €16.74 Million ≈ $19.57 Million |
-12.25% |
| 2006-12-31 | €19.08 Million ≈ $22.30 Million |
+14.29% |
| 2005-12-31 | €16.69 Million ≈ $19.51 Million |
+9.28% |
| 2004-12-31 | €15.27 Million ≈ $17.86 Million |
+14.55% |
| 2003-12-31 | €13.33 Million ≈ $15.59 Million |
-1.00% |
| 2002-12-31 | €13.47 Million ≈ $15.75 Million |
+26.44% |
| 2001-12-31 | €10.65 Million ≈ $12.45 Million |
+173.55% |
| 2000-12-31 | €3.89 Million ≈ $4.55 Million |
-- |
About Europlasma SA
Europlasma S.A., together with its subsidiaries, develops, constructs, and operates plasma torch system for industrial applications in France. The company offers plasma solutions for gas and hazardous waste; decarbonization solutions for transforming waste disposal to solid recovered fuel; and hazardous waste treatment solutions. It also manufactures and sales forged parts and anode sheets for ca… Read more